Skip to main content

Clinical trial C101

Open, non-controlled, multicenter, first-in-human study for the evaluation of the safety, pharmacokinetics and preliminary antitumor activity of GM102 in patients with advanced pretreated gynecological cancer

Cancers
Organ gynecologic
Trial status Trial open for recruitment
Investigator
Trial type
Prospective interventional
Phase Trial phase 1
Academic trial Non
Sponsor GamaMabs Pharma
EudraCT Identifier 2015-004252-22
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02978755
Inclusion criteria Any line RECIST 1.1
Last update